Coverage dated August 5, 2025

HHS ends funding for mRNA vaccines targeting respiratory viruses

Headline from BNO News

The U.S. Department of Health and Human Services (HHS) announced it is terminating 22 federal contracts related to mRNA vaccine development for respiratory viruses, including COVID-19 and influenza, following an internal review.

BNO News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

6 articles, oldest first.

  1. BNO News

    HHS ends funding for mRNA vaccines targeting respiratory viruses (opens BNO News)

    Published

    BNO News's feed description

    The U.S. Department of Health and Human Services (HHS) announced it is terminating 22 federal contracts related to mRNA vaccine development for respiratory viruses, including COVID-19 and influenza, following an internal review.

  2. Washington Examiner

    HHS cancels development of mRNA vaccines for flu and COVID (opens Washington Examiner)

    Published

    Washington Examiner's feed description

    HHS announced that it will no longer fund internal department research for mRNA vaccines for upper respiratory viruses like flu and COVID-19.

  3. ABC 12 Flint

    HHS slashes funding for mRNA vaccine development (opens ABC 12 Flint)

    Published

    ABC 12 Flint's feed description

    US Health and Human Services is "winding down" its mRNA vaccine development and will instead fund other vaccine platforms through the Biomedical Advanced Research and Development Authority.

  4. WMUR

    HHS cuts mRNA vaccine research, impacting COVID-19, flu shots (opens WMUR)

    Published

    WMUR's feed description

    Robert F. Kennedy Jr. said his department would slash funding for mRNA vaccine research and shift its focus to "whole-virus" and "universal vaccines" instead.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

HHS ends funding for mRNA vaccines targeting respiratory viruses | Since Then